483
University of Missouri - Columbia Research Reactor CenterFDA 483 - University of Missouri - Columbia Research Reactor Center - August 15, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Missouri University Reactor Research (MURR) in Columbia, MO, identified a significant deficiency in their record-keeping practices. The firm failed to maintain records for annual product reviews, specifically for Lutetium (LU-177) and another drug product, with the last reviews conducted in 2016. This indicates a lapse in evaluating drug product quality standards and determining the need for changes in manufacturing or control procedures.
- Inspection Date
- August 15, 2019
- Product Type
- Drugs
Open in Dashboard
ID · 9284e324-f469-4b2c-98d9-c986f5985906